GDPR & EU AI Act: Can a Single Provider Be Your Representative?

For non-EU companies placing products or services on the European market, appointing a local representative is a critical compliance step. Under the General Data Protection Regulation (GDPR), an Article 27 Representative acts as the primary point of contact for data subjects and supervisory authorities. With the recent introduction of the EU AI Act, a similar requirement for an Authorised Representative is established for non-EU providers of high-risk AI systems. This raises a practical and important question: can one entity fulfill both roles? While consolidating representatives into a single provider seems efficient, the required competencies for each role are fundamentally distinct. A GDPR representative’s expertise is rooted in data protection law, handling data subject access requests, and liaising with Data Protection Authorities (DPAs). Their focus is squarely on the lawful and transparent processing of personal data. In contrast, the AI Act Authorised Representative’s duties are aligned with technical product compliance and safety. This role involves ensuring the AI system's conformity assessment has been performed, maintaining technical documentation, and cooperating with market surveillance authorities on safety issues. A single provider would need to demonstrate deep, verifiable expertise in both the legal nuances of data privacy and the technical complexities of AI product regulation. Theoretically, a single entity could serve both functions, but this is a high-risk strategy that demands rigorous due diligence. The provider must possess a rare, interdisciplinary skill set to effectively manage the significant and diverse compliance obligations posed by each regulation. Companies considering a consolidated approach must scrutinize a potential provider’s ability to manage these distinct responsibilities, asking whether they have separate, qualified teams and how they would handle a simultaneous inquiry from a DPA and an AI market surveillance body. ### Key Points * **Distinct Skill Sets Required:** A GDPR Representative needs deep expertise in data protection law and privacy management, while an AI Act Authorised Representative requires technical knowledge of product compliance, risk management frameworks, and quality management systems for AI. * **Divergent Responsibilities and Authorities:** The GDPR Representative interacts with Data Protection Authorities (DPAs) regarding personal data processing. The AI Act Representative liaises with Market Surveillance Authorities concerning product safety and conformity. These are different bodies with different mandates. * **Consolidation Carries Risk:** Appointing a single provider who lacks genuine, deep expertise in either domain creates a significant compliance gap. A failure in one area does not excuse a failure in the other, and the liabilities can be substantial. * **Due Diligence is Non-Negotiable:** Before appointing a single provider for both roles, a company must conduct a thorough assessment of their capabilities, including their team structure, individual qualifications, experience in both fields, and procedures for managing potential conflicts. * **A Hybrid Model May Be Viable:** The most plausible "single provider" scenario involves a large, well-resourced firm with distinct, firewalled departments—one for data privacy legal services and another for technical product compliance—that can work in a coordinated fashion. ## Understanding the GDPR Article 27 Representative The role of the Article 27 Representative is a cornerstone of the GDPR's extraterritorial reach. It ensures that individuals in the EU have a local point of contact and that supervisory authorities can effectively enforce the regulation against companies based outside the Union. ### Who Needs an Article 27 Representative? A non-EU organization must appoint a GDPR Representative if it processes the personal data of individuals in the EU in relation to: 1. Offering goods or services to them (irrespective of whether a payment is required). 2. Monitoring their behavior as far as their behavior takes place within the EU. There is a limited exemption for processing that is occasional, does not include large-scale processing of special categories of data, and is unlikely to result in a risk to the rights and freedoms of individuals. However, most businesses with a consistent EU customer base will find they are required to appoint one. ### Core Responsibilities and Required Expertise The GDPR Representative's duties are centered on communication and record-keeping. Their expertise must be in law and privacy management. * **Primary Point of Contact:** They serve as the go-to contact for EU-based data subjects who wish to exercise their rights (e.g., access, rectification, erasure) and for Data Protection Authorities (DPAs) conducting inquiries or investigations. * **Maintain Record of Processing Activities (RoPA):** The representative must hold and maintain a copy of the company’s RoPA and make it available to supervisory authorities upon request. The RoPA is a detailed log of all personal data processing activities. * **Facilitate Communication:** They act as a bridge, ensuring that communications from data subjects and DPAs are passed to the non-EU company and that responses are managed appropriately. * **Cooperate with Authorities:** In the event of an investigation, the representative is legally mandated to cooperate fully with the relevant DPA. The required skill set is legal and procedural. A qualified GDPR Representative understands the nuances of data protection law across different EU member states, is experienced in handling DPA inquiries, and can effectively manage data subject requests. ## Understanding the EU AI Act Authorised Representative The EU AI Act introduces a parallel but distinct role for non-EU providers of high-risk AI systems. This role is modeled on existing EU product safety legislation and is focused on ensuring that AI systems placed on the market are safe and compliant with the Act's technical and procedural requirements. ### Who Needs an AI Act Authorised Representative? A provider of a high-risk AI system that is not established in the EU must, by written mandate, appoint an Authorised Representative within the Union before making that system available on the market. This applies to a wide range of systems, including those used in medical devices, critical infrastructure, employment, and law enforcement. ### Core Responsibilities and Required Expertise The AI Act Representative's duties are technical and focused on product compliance. Their expertise must be in regulatory affairs, quality management, and technical standards. * **Verify Compliance Documentation:** They are responsible for verifying that the EU declaration of conformity and the required technical documentation have been properly drawn up by the non-EU provider. * **Maintain Access to Documentation:** They must keep a copy of the declaration of conformity, technical documentation, and any relevant logs generated by the AI system, and be ready to provide them to national competent authorities upon request. * **Cooperate with Market Surveillance:** The representative is the primary contact for market surveillance authorities. They must provide all necessary information and cooperate in any actions taken to eliminate the risks posed by the high-risk AI system. * **Risk Mitigation and Reporting:** If the representative believes an AI system presents a risk, they must inform the provider and the relevant authorities. They also handle complaints and reports from individuals about potential risks. The required skill set is technical and regulatory. A qualified AI Act Representative understands conformity assessment procedures, risk management frameworks (e.g., ISO 31000), quality management systems (e.g., ISO 13485 for medical devices), and the specific technical standards applicable to AI. ## The Challenge of a Dual Mandate: Key Differences to Scrutinize The core challenge in appointing a single provider for both roles lies in the fundamental differences between their functions, the authorities they answer to, and the expertise required. | Feature | GDPR Article 27 Representative | AI Act Authorised Representative | | :--- | :--- | :--- | | **Primary Focus** | Data Protection & Individual Privacy Rights | Technical Product Safety & Market Compliance | | **Governing Law** | General Data Protection Regulation (GDPR) | EU AI Act | | **Key Authority** | Data Protection Authorities (DPAs) | National Market Surveillance Authorities | | **Core Document** | Record of Processing Activities (RoPA) | Technical Documentation & EU Declaration of Conformity | | **Required Skill Set** | Legal (Privacy Law, DPA Procedures) | Technical/Regulatory (QMS, Risk Management, Conformity Assessment) | | **Liability Focus** | Unlawful data processing, data breaches | Unsafe or non-compliant products on the market | ## How to Vet a Potential Dual-Role Provider: A Due Diligence Checklist If a company still wishes to explore a consolidated representative model, it must conduct exceptionally thorough due diligence. A superficial evaluation is insufficient; the assessment must probe the provider's genuine, demonstrable capabilities in both domains. Use the following checklist to guide your vetting process: **1. Expertise and Qualifications** * **GDPR Team:** Request the CVs and certifications (e.g., CIPP/E, CIPM) of the individuals who will specifically handle GDPR matters. Do they have a legal background and experience interacting with DPAs? * **AI Act Team:** Request the CVs and qualifications of the individuals who will handle AI Act compliance. Do they have engineering or regulatory affairs backgrounds? What is their experience with product conformity, QMS audits, and technical documentation for complex software or medical devices? **2. Team Structure and Segregation of Duties** * Does the provider operate with two distinct, specialized teams? * How are responsibilities segregated? A single person cannot realistically be an expert in both areas. * Ask for an organizational chart that clearly shows the reporting lines for the data privacy function and the product compliance function. **3. Experience and Case Studies** * **GDPR Experience:** Ask for anonymized examples of how they have managed complex data subject requests or formal inquiries from a DPA. * **AI Act/Product Compliance Experience:** While the AI Act is new, ask for their experience as an Authorised Representative under other EU product regulations (e.g., the Medical Device Regulation - MDR). How have they handled a product recall or an investigation from a market surveillance authority? **4. Conflict Management and Procedures** * Present a hypothetical scenario: "What is your process if we face a simultaneous, urgent investigation from the Irish Data Protection Commission regarding a data breach and a recall request from the German market surveillance authority for our AI product?" * Their answer should detail how two separate teams would manage these crises concurrently without compromising either response. **5. Liability and Professional Insurance** * Review their service agreement and liability clauses carefully. * Ask for proof of professional indemnity insurance. Does the policy explicitly cover failures related to both data protection legal advice *and* technical product safety/compliance? A standard legal malpractice policy may not cover a failure related to product conformity. ## Finding and Comparing GDPR Article 27 Representative Providers Choosing the right GDPR Article 27 Representative is a crucial compliance decision. The ideal partner not only fulfills the legal requirement but also acts as a knowledgeable resource, helping your organization navigate the complexities of EU data protection. When evaluating providers, look beyond price and consider their experience, responsiveness, and the clarity of their service offerings. A transparent provider will clearly define the scope of their services, what is included in their standard fee, and what constitutes an additional service (e.g., managing a complex DPA investigation). Comparing providers helps ensure you find a representative that fits your company's specific risk profile and operational needs. It is essential to find a partner with proven expertise in dealing with the specific DPAs relevant to your business. > To find qualified vetted providers [click here](https://cruxi.ai/regulatory-directories/gdpr_art27_rep) and request quotes for free. ## Key Regulatory Concepts and References While the EU GDPR and AI Act create distinct representative roles, the concept of appointing a local representative for regulatory purposes is a common feature in global regulations. Understanding these models helps contextualize the importance of specialized knowledge. * **EU GDPR:** Article 27 establishes the requirement for a representative for non-EU controllers and processors to act as a point of contact for supervisory authorities and data subjects. * **EU AI Act:** This regulation mandates the appointment of an Authorised Representative for non-EU providers of high-risk AI systems to ensure product safety and compliance with market surveillance. * **US FDA Framework:** For comparison, the U.S. Food and Drug Administration (FDA) requires foreign establishments involved in the manufacturing of medical devices for the U.S. market to designate a "U.S. Agent." As outlined in regulations such as **21 CFR** Part 807, the U.S. Agent's role is primarily for communication with the FDA. While less extensive than an EU Authorised Representative's duties, it demonstrates a similar principle of local representation. Various **FDA guidance** documents further clarify the responsibilities of different parties in the regulatory process. This comparison highlights how each jurisdiction tailors the representative role to its specific legal and regulatory focus—data in the EU, and product safety in the US—underscoring why jurisdiction-specific expertise is paramount. *** This article is for general educational purposes only and is not legal, medical, or regulatory advice. For device-specific questions, sponsors should consult qualified experts and consider engaging FDA via the Q-Submission program. --- *This answer was AI-assisted and reviewed for accuracy by Lo H. Khamis.*